News Center Events Publications

MGI and AmCare Genomics Laboratory reached strategic cooperation in genetic diseases

Recently, Shenzhen MGI Technology Co., Ltd. and AmCare Genomics Laboratory reached a strategic cooperation agreement in the clinical application direction of single gene genetic disease detection. AmCare Genomics Laboratory will develop a whole-process overall solution for genetic testing of single-gene genetic diseases based on MGI's high-throughput sequencing platform to realize the localization, automation and intelligence of genetic disease testing from sample to report interpretation.

MGI launches first "benchtop” sequencing laboratory and automation products — accelerating portable, intelligent and flexible genetic sequencing

Accelerating portable, intelligent and flexible genetic sequencing

Interview with Paul Lundquist | When physics meets life sciences, it opens the door to new discoveries in life sciences with interdisciplinary ideas

Paul Lundquist joined MGI as vice president of Engineering in 2018. He holds a Ph.D. in Physics from Northwestern University. Dr. Lundquist started out doing basic research at the IBM-Almaden Research Center and moved from there to early-stage startups. He was the first engineer at Pacific Biosciences. Moving from a novel idea to commercial success takes deep expertise in very disparate fields, integrating the expertise of outsiders, and a willingness to continually adapt, he said. MGI is an exciting place to be, and most Silicon Valley startups would envy its progress over the last two years. For him the most rewarding work lies in seeing new technology used to solve difficult medical issues and raise the standards of healthcare for people who need it most.

MGI Demonstrates Success of New CoolMPS™ Sequencing Chemistry on PCR-free DNBSEQ™ Platform

MGI, a subsidiary of global genomics leader BGI Group, said early research results from its revolutionary CoolMPS™ proprietary sequencing technology performed with high accuracy, reproducibility and cost effectiveness, leading the way toward more efficient and accurate Massively Parallel Sequencing (MPS). MGI also reported that its DNBSEQ-T7 genetic sequencer, the world's most powerful, was successfully delivered to multiple customers in China.
4000-966-988Hot Line

Wechat Wechat